ArticleOpen forum infectious diseases2025
Trends in Incidence and Epidemiology of Methicillin-Resistant
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Trends in Mortality and the Effects of the Coronavirus Disease 2019 Pandemic on Mortality Among Adult Patients WithOpen forum infectious diseases · 2026Article
- Structural basis for the procoagulant activity ofBiological chemistry · 2026Review
- Antimicrobial Resistance in Major Gram-Positive Pathogens: Beyond the Vancomycin Border.Antibiotics (Basel, Switzerland) · 2026Review
- Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026Review
- The global epidemiology of MRSA.JAC-antimicrobial resistance · 2026Review
- Efficacy and Cost Analysis of a Combined (One-Step) Detergent-Disinfectant for Environmental Decontamination Around Methicillin-ResistantInfectious diseases & clinical microbiology · 2026Article
- Post-COVID impairment of T cell responses to community-acquired pathogens can be modified by activating cellular metabolism.PLoS pathogens · 2026Article
- Identification of targetable epitope surfaces from the high resolution structure of the superantigen Staphylococcal enterotoxin L.Scientific reports · 2026Article
- MRSA nasal carriage among Taiwanese senior high school students and a narrative review of local metadata.New microbes and new infections · 2026Article
- Monitoring the Burden ofAntibiotics (Basel, Switzerland) · 2026Article
- Population genomic variation inMicrobial genomics · 2026Article
- Hospital-onset methicillin-resistantInfection control and hospital epidemiology · 2026Article
- Trends, Seasonality, and the Impact of COVID-19 on ClinicalAntibiotics (Basel, Switzerland) · 2026Article
- Genomic insights and emerging therapeutics in community-associated MRSA.Annals of medicine and surgery (2012) · 2026Article
- Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Background: The impact of the coronavirus disease 2019 (COVID-19) pandemic on methicillin-resistant Methods: Active laboratory- and population-based surveillance identified incident MRSA blood isolates among surveillance area residents in 6 continuously reporting sites during 2005-2022. Annual incidence per 100 000 census population was stratified by epidemiologic classification (hospital-onset, community-associated, health care-associated community-onset). Joinpoint with Poisson regression was used to determine incidence trend segments and annual percent change (APC; 2005-2019) and predicted incidence (2020-2022). Recent COVID-19 was a positive severe acute respiratory syndrome coronavirus 2 viral test ≤30 days before incident MRSA culture. Results: Overall declines in MRSA bacteremia incidence during 2005-2016 (APC, -7.1; Conclusions: Previous declines in MRSA bacteremia incidence had ended before the COVID-19 pandemic. During 2020-2022, patients with recent COVID-19 contributed substantially to increases in hospital-onset MRSA bacteremia, suggesting a need for robust infection prevention in this population. Reversal of prepandemic increases in health care-associated community-onset and community-associated infections during the pandemic could be related to COVID-19 mitigation measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.